Correspondence on editorial regarding "Novel role of MHC class II transactivator in hepatitis B virus replication and viral counteraction"

被引:0
|
作者
Dezhbord, Mehrangiz [1 ]
Kim, Kyun-Hwan [1 ]
机构
[1] Sungkyunkwan Univ, Dept Precis Med, Sch Med, Nat Sci Campus,2066 Seobu Ro, Suwon 16419, South Korea
基金
新加坡国家研究基金会;
关键词
MHC class II transactivator; HBV X protein; Immune evasion; EXPRESSION; ANTIGENS; CIITA;
D O I
10.3350/cmh.2024.0515
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页数:4
相关论文
共 42 条
  • [21] Novel mutations within the RFX-B gene and partial rescue of MHC and related genes through exogenous class II transactivator in RFX-B-deficient cells
    Nagarajan, UM
    Peijnenburg, A
    Gobin, SJP
    Boss, JM
    van den Elsen, PJ
    JOURNAL OF IMMUNOLOGY, 2000, 164 (07): : 3666 - 3674
  • [22] Major Histocompatibility Complex Class II Transactivator CIITA Is a Viral Restriction Factor That Targets Human T-Cell Lymphotropic Virus Type 1 Tax-1 Function and Inhibits Viral Replication
    Tosi, Giovanna
    Forlani, Greta
    Andresen, Vibeke
    Turci, Marco
    Bertazzoni, Umberto
    Franchini, Genoveffa
    Poli, Guido
    Accolla, Roberto S.
    JOURNAL OF VIROLOGY, 2011, 85 (20) : 10719 - 10729
  • [23] Scavenger receptor class B member 1 (SCARB1) variants modulate hepatitis C virus replication cycle and viral load
    Westhaus, Sandra
    Deest, Maximilian
    Nguyen, Anna T. X.
    Stanke, Frauke
    Heckl, Dirk
    Costa, Rui
    Schambach, Axel
    Manns, Michael P.
    Berg, Thomas
    Vondran, Florian W. R.
    Sarrazin, Christoph
    Ciesek, Sandra
    von Hahn, Thomas
    JOURNAL OF HEPATOLOGY, 2017, 67 (02) : 237 - 245
  • [24] RELATIONSHIP BETWEEN THE REACTIVITY TO HEPATITIS-B VIRUS VACCINATION AND THE FREQUENCY OF MHC CLASS-I, CLASS-II AND CLASS-III ALLELES IN HEMODIALYSIS-PATIENTS
    STACHOWSKI, J
    KRAMER, J
    FUST, G
    MACIEJEWSKI, J
    BALDAMUS, CA
    PETRANYI, GG
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1995, 42 (01) : 60 - 65
  • [25] The Novel Immunosuppressive Protein Kinase C Inhibitor Sotrastaurin Has No Pro-Viral Effects on the Replication Cycle of Hepatitis B or C Virus
    von Hahn, Thomas
    Schulze, Andreas
    Wust, Ivan Chicano
    Heidrich, Benjamin
    Becker, Thomas
    Steinmann, Eike
    Helfritz, Fabian A.
    Rohrmann, Katrin
    Urban, Stephan
    Manns, Michael P.
    Pietschmann, Thomas
    Ciesek, Sandra
    PLOS ONE, 2011, 6 (09):
  • [26] MHC CLASS II-RESTRICTED T-CELL-RECEPTORS PROVIDE HELP FOR T-CELL-THERAPY OF HEPATITIS B VIRUS INFECTION
    Schreiber, S.
    Wettengel, J.
    Krey, K.
    Wisskirchen, K.
    Protzer, U.
    HUMAN GENE THERAPY, 2022, 33 (7-8) : A31 - A31
  • [27] CORE ANTIGEN MUTATIONS OF HUMAN HEPATITIS-B VIRUS IN HEPATOMAS ACCUMULATE IN MHC CLASS II-RESTRICTED T-CELL EPITOPES
    HOSONO, S
    TAI, PC
    WANG, W
    AMBROSE, M
    HWANG, DGY
    YUAN, TT
    PENG, BH
    YANG, CS
    LEE, CS
    SHIH, CH
    VIROLOGY, 1995, 212 (01) : 151 - 162
  • [28] CLASS II PHOSPHATIDYLINOSITOL 3-KINASE 2β IS A NOVEL TARGET FOR THE POTENTIAL DEVELOPMENT OF ANTIVIRAL DRUGS AGAINST THE HEPATITIS B VIRUS
    Patriche, David
    Popescu, Mirela
    Popescu, Costin-Ioan
    Nichita, Norica
    FARMACIA, 2022, 70 (02) : 266 - 271
  • [29] RB AND A NOVEL E2F-1 BINDING-PROTEIN IN MHC CLASS-II DEFICIENT B-CELL LINES AND NORMAL IFN-GAMMA INDUCTION OF THE CLASS-II TRANSACTIVATOR CIITA IN CLASS-II NONINDUCIBLE RB-DEFECTIVE TUMOR LINES
    TSCHICKARDT, ME
    LU, YM
    JACIM, M
    USSERY, GDW
    STEIMLE, V
    MACH, B
    BLANCK, G
    INTERNATIONAL JOURNAL OF CANCER, 1995, 62 (04) : 461 - 465
  • [30] Risk of Hepatitis B Virus (HBV) Reactivation and the Role of Anti-Viral Prophylaxis in Multiple Myeloma Patients with HBV Infection in the Era of Novel Therapies
    Mya, Dawn
    Han, Shuting
    Goh, Yeow Tee
    Tan, Daryl
    BLOOD, 2009, 114 (22) : 1493 - 1494